Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program.
- DOI
- 10.1016/j.cct.2022.106922
- Published
- 2022-09-10
- Container
- Contemp Clin Trials
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cct.2022.106922,
title = {Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program.},
author = {Gerber DE and Tiro JA and McNeill LH and Williams EL and Zhu H and Lee SJC and Leavey PJ and Sadeghi N and Kapinos KA and Dornsife DL and Nguyen V and Wileyto EP and Guerra CE.},
year = {2022},
journal = {Contemp Clin Trials},
doi = {10.1016/j.cct.2022.106922},
url = {https://doi.org/10.1016/j.cct.2022.106922}
}RIS
TY - JOUR TI - Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program. AU - Gerber DE AU - Tiro JA AU - McNeill LH AU - Williams EL AU - Zhu H AU - Lee SJC AU - Leavey PJ AU - Sadeghi N AU - Kapinos KA AU - Dornsife DL AU - Nguyen V AU - Wileyto EP AU - Guerra CE. PY - 2022 JO - Contemp Clin Trials DO - 10.1016/j.cct.2022.106922 UR - https://doi.org/10.1016/j.cct.2022.106922 ER -
APA
DE, G., JA, T., LH, M., EL, W., H, Z., SJC, L., PJ, L., N, S., KA, K., DL, D., V, N., EP, W., & CE., G. (2022). Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program.. Contemp Clin Trials. https://doi.org/10.1016/j.cct.2022.106922
Source records
- europe-pmc · retrieved 2026-09-26T03:16:00.160Z